Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 9/2007

01-09-2007 | Original article

Regional CBF changes in Parkinson’s disease: a correlation with motor dysfunction

Authors: Jung-Lung Hsu, Tzyy-Ping Jung, Chien-Yeh Hsu, Wei-Chih Hsu, Yen-Kung Chen, Jeng-Ren Duann, Han-Cheng Wang, Scott Makeig

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 9/2007

Login to get access

Abstract

Purpose

The purpose of this study was to further localize cerebral perfusion abnormalities, and to better correlate these abnormalities with the clinical severity of Parkinson’s disease (PD).

Methods

A single-photon emission computed tomography (SPECT) study was performed on 27 patients with PD and 24 age-matched controls. SPECT images were spatially normalized, concatenated, and then decomposed using Infomax independent component analysis (ICA). The resulting image components were separated by logistic regression into two subspaces: “disease-related” components whose subject weights differed between groups, and “disease-unrelated” components. The resultant regional cerebral blood flow (rCBF) subspace images were normalized to global CBF for each subject, and then processed using statistical parametric mapping to compare rCBF values between PD and control subjects.

Results

In the disease-related image subspace, patients with PD exhibited significantly higher adjusted rCBF in the putamen, globus pallidum, thalamus, brainstem, and the anterior lobe of the cerebellum, and significant hypoperfusion in the parieto-temporo-occipital cortex, the dorsolateral prefrontal cortex, the insula, and the cingulate gyrus. The motor Unified Parkinson’s Disease Rating Scale scores correlated negatively with rCBF in the insula and cingulate gyrus. In the disease-unrelated image subspace, no brain voxels exhibited a significant group difference.

Conclusion

ICA-based separation of normalized images into disease-related and disease-unrelated subspaces revealed many disease-related group blood flow differences. The regions revealed by ICA are consistent with the current model of PD. These rCBF changes in PD have not been fully demonstrated in any single functional imaging study previously.
Literature
1.
go back to reference Hornykiewcz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 1966;18:925–64. Hornykiewcz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 1966;18:925–64.
2.
go back to reference Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366–75.PubMedCrossRef Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366–75.PubMedCrossRef
3.
go back to reference Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266–71.PubMedCrossRef Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266–71.PubMedCrossRef
4.
go back to reference Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer’s disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992;32:181–5. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer’s disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992;32:181–5.
5.
go back to reference Perlmutter JS, Raichle ME. Regional blood flow in hemiparkinsonism. Neurology 1985;35:1127–34.PubMed Perlmutter JS, Raichle ME. Regional blood flow in hemiparkinsonism. Neurology 1985;35:1127–34.PubMed
6.
go back to reference Henriksen L, Boas J. Regional cerebral blood flow in hemiparkinsonian patients: emission computerized tompgraphy of inhaled 133Xenon before and after levodopa. Acta Neurol Scand 1985;71:257–66.PubMedCrossRef Henriksen L, Boas J. Regional cerebral blood flow in hemiparkinsonian patients: emission computerized tompgraphy of inhaled 133Xenon before and after levodopa. Acta Neurol Scand 1985;71:257–66.PubMedCrossRef
7.
go back to reference Wolfson LI, Leenders KL, Brown LL, Jones T. Alterations of cerebral blood flow and oxygen metabolism in Parkinson’s disease. Neurology 1985;35:1399–405.PubMed Wolfson LI, Leenders KL, Brown LL, Jones T. Alterations of cerebral blood flow and oxygen metabolism in Parkinson’s disease. Neurology 1985;35:1399–405.PubMed
8.
go back to reference Pizzolato G, Dam M, Borsato N, Saitta B, Da Col C, Perlotto N, et al. 99mTc-HMPAO SPECT in Parkinson’s disease. J Cereb Blood Flow Metab 1988;8(suppl):S101–8.PubMed Pizzolato G, Dam M, Borsato N, Saitta B, Da Col C, Perlotto N, et al. 99mTc-HMPAO SPECT in Parkinson’s disease. J Cereb Blood Flow Metab 1988;8(suppl):S101–8.PubMed
9.
go back to reference Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson’s disease. J Nucl Med 1999;40;1583–9.PubMed Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson’s disease. J Nucl Med 1999;40;1583–9.PubMed
10.
go back to reference Vaasinen V, Maguire RP, Hundemer HP, Leenders KL. Corticostriatal covariance patterns of 6-[F18]fluoro-L-dopa and [F18]fluorodeoxyglucose PET in Parkinson’s disease. J Neurol 2006;253:340–8.CrossRef Vaasinen V, Maguire RP, Hundemer HP, Leenders KL. Corticostriatal covariance patterns of 6-[F18]fluoro-L-dopa and [F18]fluorodeoxyglucose PET in Parkinson’s disease. J Neurol 2006;253:340–8.CrossRef
11.
go back to reference Dujardin K, Defebvre L, Duhamel A, Lecouffe P, Rogelet P, Steinling M, et al. Cognitive and SPECT characteristics predict progression of Parkinson’s disease in newly diagnosed patients. J Neurol 2004;251:1383–92.PubMedCrossRef Dujardin K, Defebvre L, Duhamel A, Lecouffe P, Rogelet P, Steinling M, et al. Cognitive and SPECT characteristics predict progression of Parkinson’s disease in newly diagnosed patients. J Neurol 2004;251:1383–92.PubMedCrossRef
12.
go back to reference Bell AJ, Sejnowski TJ. An information-maximization approach to blind separation and blind deconvolution. Neural Comput 1995;7(6):1129–59.PubMed Bell AJ, Sejnowski TJ. An information-maximization approach to blind separation and blind deconvolution. Neural Comput 1995;7(6):1129–59.PubMed
13.
go back to reference Jung T-P, Makeig S, McKeown MJ, Bell AJ, Lee T-W, Sejnowski TJ. Imaging brain dynamics using independent component analysis. Proc IEEE 2001;89:1107–22. Jung T-P, Makeig S, McKeown MJ, Bell AJ, Lee T-W, Sejnowski TJ. Imaging brain dynamics using independent component analysis. Proc IEEE 2001;89:1107–22.
14.
go back to reference McKeown MJ, Makeig S, Brown GG, Jung T-P, Kindermann SS, Sejnowski TJ. Analysis of fMRI by blind separation into independent spatial components. Hum Brain Mapp 1988:6:160–88.CrossRef McKeown MJ, Makeig S, Brown GG, Jung T-P, Kindermann SS, Sejnowski TJ. Analysis of fMRI by blind separation into independent spatial components. Hum Brain Mapp 1988:6:160–88.CrossRef
15.
go back to reference Ward CD, Gibb WR. Research diagnostic criteria for Parkinson’s disease. Adv Neurol 1990;53:245–9.PubMed Ward CD, Gibb WR. Research diagnostic criteria for Parkinson’s disease. Adv Neurol 1990;53:245–9.PubMed
16.
go back to reference Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–42.PubMed Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–42.PubMed
17.
go back to reference Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson’s disease and movement disorders. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson’s disease vol 2. Florham Park: NJ Mcmillan Health Care Information; 1987. pp. 153–64. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson’s disease and movement disorders. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson’s disease vol 2. Florham Park: NJ Mcmillan Health Care Information; 1987. pp. 153–64.
18.
go back to reference Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638–43.CrossRef Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638–43.CrossRef
19.
go back to reference Duann JR, Jung TP, Kuo WJ, Yeh TC, Makeig S, Hsieh JC, et al. Single-trial variability in event-related BOLD signals. Neuroimage 2002;15:823–35.PubMedCrossRef Duann JR, Jung TP, Kuo WJ, Yeh TC, Makeig S, Hsieh JC, et al. Single-trial variability in event-related BOLD signals. Neuroimage 2002;15:823–35.PubMedCrossRef
20.
go back to reference Makeig S, Jung TP, Bell AJ, Ghahremani D, Sejnowski TJ. Blind separation of auditory event-related brain responses into independent components. Proc Natl Acad Sci USA 1997;94:10979–84.PubMedCrossRef Makeig S, Jung TP, Bell AJ, Ghahremani D, Sejnowski TJ. Blind separation of auditory event-related brain responses into independent components. Proc Natl Acad Sci USA 1997;94:10979–84.PubMedCrossRef
21.
go back to reference Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991;11:690–9.PubMed Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991;11:690–9.PubMed
22.
go back to reference Friston KJ, Worsley KJ, Frackowiak RSJ, Mazziotta JC, Evans AC. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1994;1:214–20.CrossRef Friston KJ, Worsley KJ, Frackowiak RSJ, Mazziotta JC, Evans AC. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1994;1:214–20.CrossRef
23.
go back to reference Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, et al. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson’s disease. J Neurol Sci 2001;193:29–36.PubMedCrossRef Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, et al. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson’s disease. J Neurol Sci 2001;193:29–36.PubMedCrossRef
24.
go back to reference Dogali M, Fazzini E, Kolodny E, Eidelberg D, Sterio D, Devinsky O, et al. Stereotactic ventral pallidotomy for Parkinson’s disease. Neurology 1995;45:753–61.PubMed Dogali M, Fazzini E, Kolodny E, Eidelberg D, Sterio D, Devinsky O, et al. Stereotactic ventral pallidotomy for Parkinson’s disease. Neurology 1995;45:753–61.PubMed
25.
go back to reference Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, et al. Bilateral subthalamotomy in Parkinson’s disease: initial and long-term response. Brain 2005;128:570–83.PubMedCrossRef Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, et al. Bilateral subthalamotomy in Parkinson’s disease: initial and long-term response. Brain 2005;128:570–83.PubMedCrossRef
26.
go back to reference Antonini A, Vontobel P, Psylla M, Gunther I, Maguire PR, Missimer J, et al. Complememtary positron emsission tomographic studies of the striatal dopaminergic system in Parkinson’s disease. Arch Neurol 1995;52:1183–90.PubMed Antonini A, Vontobel P, Psylla M, Gunther I, Maguire PR, Missimer J, et al. Complememtary positron emsission tomographic studies of the striatal dopaminergic system in Parkinson’s disease. Arch Neurol 1995;52:1183–90.PubMed
27.
go back to reference Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson’s disease. J Cereb Blood Flow Metab 2004;24:7–16.PubMedCrossRef Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson’s disease. J Cereb Blood Flow Metab 2004;24:7–16.PubMedCrossRef
28.
go back to reference Ghaemi M, Raethjen J, Hilker R, Rudolf J, Sobesky J, Deuschl G, et al. Monosymptomatic resting tremor and Parkinson’s disease: a multitracer positron emission tomographic study. Mov Disord 2002;17:782–8.PubMedCrossRef Ghaemi M, Raethjen J, Hilker R, Rudolf J, Sobesky J, Deuschl G, et al. Monosymptomatic resting tremor and Parkinson’s disease: a multitracer positron emission tomographic study. Mov Disord 2002;17:782–8.PubMedCrossRef
29.
go back to reference Goerendt IK, Lawrence AD, Mehta MA, Stern JS, Odin P, Brooks DJ. Distributed neural actions of anti-parkinsonian therapies as revealed by PET. J Neural Transm 2006;113:75–86.PubMedCrossRef Goerendt IK, Lawrence AD, Mehta MA, Stern JS, Odin P, Brooks DJ. Distributed neural actions of anti-parkinsonian therapies as revealed by PET. J Neural Transm 2006;113:75–86.PubMedCrossRef
30.
go back to reference Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H. Regional cerebral flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 2005;65:1708–15.PubMedCrossRef Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H. Regional cerebral flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 2005;65:1708–15.PubMedCrossRef
31.
go back to reference Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O’Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003;20:1309–19.PubMedCrossRef Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O’Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003;20:1309–19.PubMedCrossRef
32.
go back to reference Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson’s disease. Neurol Sci 2001;22:47–8.PubMedCrossRef Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson’s disease. Neurol Sci 2001;22:47–8.PubMedCrossRef
33.
go back to reference Arahata Y, Hirayama M, Ieda T, Koike Y, Kato T, Tadokoro M, et al. Parieto-occipital glucose hypometabolism in Parkinson’s disease with autonomic failure. J Neurol Sci 1999;163:119–26.PubMedCrossRef Arahata Y, Hirayama M, Ieda T, Koike Y, Kato T, Tadokoro M, et al. Parieto-occipital glucose hypometabolism in Parkinson’s disease with autonomic failure. J Neurol Sci 1999;163:119–26.PubMedCrossRef
34.
go back to reference Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s disease. Ann Neurol 1990;28:57–64.PubMedCrossRef Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s disease. Ann Neurol 1990;28:57–64.PubMedCrossRef
35.
go back to reference Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T, et al. Resting regional cerebral glucose metabolism in advanced Parkinson’s disease studied in the off and on conditions with [18F]FDG-PET. Mov Disord 2001;16:1014–22.PubMedCrossRef Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T, et al. Resting regional cerebral glucose metabolism in advanced Parkinson’s disease studied in the off and on conditions with [18F]FDG-PET. Mov Disord 2001;16:1014–22.PubMedCrossRef
36.
go back to reference Black KJ, Hershey T, Hartlein JM, Carl JL, Perlmutter JS. Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson’s disease. Neuropsychopharmacology 2005;30:590–601.PubMedCrossRef Black KJ, Hershey T, Hartlein JM, Carl JL, Perlmutter JS. Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson’s disease. Neuropsychopharmacology 2005;30:590–601.PubMedCrossRef
37.
go back to reference Sestini S, Scotto di Luzio A, Ammannati F, De Cristofaro MT, Passeri A, Martini S, et al. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson’s disease. J Nucl Med 2002;43:725–32.PubMed Sestini S, Scotto di Luzio A, Ammannati F, De Cristofaro MT, Passeri A, Martini S, et al. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson’s disease. J Nucl Med 2002;43:725–32.PubMed
38.
go back to reference Lozza C, Marie RM, Baron JC. The metabolic substrates of bradykinesia and tremor in uncomplicated Parkinson’s disease. Neuroimage 2002;17:688–99.PubMedCrossRef Lozza C, Marie RM, Baron JC. The metabolic substrates of bradykinesia and tremor in uncomplicated Parkinson’s disease. Neuroimage 2002;17:688–99.PubMedCrossRef
39.
go back to reference Nagano-Saito A, Kato T, Arahata Y, Washimi Y, Nakamura A, Abe Y, et al. Cognitive- and motor-related regions in Parkinson’s disease: FDOPA and FDG PET studies. Neuroimage 2004;22:553–61.PubMedCrossRef Nagano-Saito A, Kato T, Arahata Y, Washimi Y, Nakamura A, Abe Y, et al. Cognitive- and motor-related regions in Parkinson’s disease: FDOPA and FDG PET studies. Neuroimage 2004;22:553–61.PubMedCrossRef
40.
go back to reference Mito Y, Yoshida K, Yabe I, Makino K, Tashiro K, Kikuchi S, et al. Brain SPECT analysis by 3D-SSP and phenotype of Parkinson’s disease. J Neurol Sci 2006;241:67–72.PubMedCrossRef Mito Y, Yoshida K, Yabe I, Makino K, Tashiro K, Kikuchi S, et al. Brain SPECT analysis by 3D-SSP and phenotype of Parkinson’s disease. J Neurol Sci 2006;241:67–72.PubMedCrossRef
Metadata
Title
Regional CBF changes in Parkinson’s disease: a correlation with motor dysfunction
Authors
Jung-Lung Hsu
Tzyy-Ping Jung
Chien-Yeh Hsu
Wei-Chih Hsu
Yen-Kung Chen
Jeng-Ren Duann
Han-Cheng Wang
Scott Makeig
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 9/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-006-0360-7

Other articles of this Issue 9/2007

European Journal of Nuclear Medicine and Molecular Imaging 9/2007 Go to the issue